Home Technology News Room Site Map Reference Shelf

About Dynacell Life Sciences Activities Industry Links
Technology

[Stem and Progenitor Cells | Biological Scaffolds]

CD34+ Hematopoietic Stem Cells

CD34, a single-pass type I transmembrane  
glycoprotein, is typically expressed on
lymphohematopoietic stem and progenitor cells.

CD34+ fractions enriched from human cord
blood are up to 100-fold enriched in various colony forming units (CFUs), including CFU-blast, CFU-macrophage, CFU-granulocyte as well as burst forming-erythroid (BFU-E).
In vivo and in vitro, as these cells mature and differentiate, the level of CD34 expression on the cell surface decreases. CD34+ cells are capable of maintaining long-term hematopoiesis.

Current methodologies utilizing CD34+ enriched fractions from human cord blood include
ex vivo genetic modification, transplant and engraftment studies, graft versus host disease studies, drug resistance gene delivery anticancer vaccination research, as well as toxicological testing.


 

Ordering Information

Primary CD34+ Cells
Catalog Number
Aliquot
26-0001-19
500,000 Cells
26-0001-21
1,000,000 Cells
26-0001-23
5,000,000 Cells
Expanded CD34+ Cells
Catalog Number
Aliquot
26-0005-19
500,000 Cells
26-0005-21
1,000,000 Cells
26-0005-23
5,000,000 Cells

        Download Technical Bulletin Number 5

       Download the Quality Specifications

       Request More Information



CD refers to Cluster of Differentiation.

Copyright 2008, Dynacell Life Sciences, LLC.

THESE PRODUCTS ARE FOR RESEARCH USE ONLY. Not approved for human or veterinary use, for application to humans or animals, or for in vitro diagnostic or clinical procedures.
WARNING: Preserved Cells CONTAIN HUMAN SOURCE MATERIAL, TREAT AS POTENTIALLY INFECTIOUS.